{
    "id": 2800,
    "fullName": "MAP2K7 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type MAP2K7 indicates that no mutation has been detected within the MAP2K7 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5609,
        "geneSymbol": "MAP2K7",
        "terms": [
            "MAP2K7",
            "JNKK2",
            "MAPKK7",
            "MEK",
            "MEK 7",
            "MKK7",
            "PRKMK7",
            "SAPKK-4",
            "SAPKK4"
        ]
    },
    "variant": "wild-type",
    "createDate": "12/19/2014",
    "updateDate": "02/19/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1503,
            "approvalStatus": "Preclinical",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, DTP3, a synthesized D-tripeptide, demonstrated potent and select activity against multiple myeloma in cell assays and xenograft models (PMID: 25314077). DTP3 disrupted the GADD45B/MAP2K7 interaction, reversing the inhibition of the JNK pathway and inducing apoptosis in cells with aberrant NF-kappaB signaling (PMID: 11713530, PMID: 25314077).",
            "molecularProfile": {
                "id": 2615,
                "profileName": "MAP2K7 wild-type"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1428,
                    "pubMedId": 25314077,
                    "title": "Cancer-selective targeting of the NF-\u03baB survival pathway with GADD45\u03b2/MKK7 inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25314077"
                },
                {
                    "id": 1429,
                    "pubMedId": 11713530,
                    "title": "Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11713530"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2615,
            "profileName": "MAP2K7 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}